Single-Agent Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis after Human Leukocyte Antigen-Matched Related Bone Marrow Transplantation for Pediatric and Young Adult Patients with Hematologic Malignancies.
about
Predictive Value of Clinical Findings and Plasma Biomarkers after Fourteen Days of Prednisone Treatment for Acute Graft-versus-host Disease.Low immunosuppressive burden after HLA-matched related or unrelated BMT using posttransplantation cyclophosphamide.Post-Transplantation Cyclophosphamide after Bone Marrow Transplantation Is Not Associated with an Increased Risk of Donor-Derived Malignancy.Clofarabine-based reduced intensity conditioning regimen with peripheral blood stem cell graft and post-transplant cyclophosphamide in adults with myeloid malignancies
P2860
Single-Agent Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis after Human Leukocyte Antigen-Matched Related Bone Marrow Transplantation for Pediatric and Young Adult Patients with Hematologic Malignancies.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Single-Agent Post-Transplantat ...... with Hematologic Malignancies.
@ast
Single-Agent Post-Transplantat ...... with Hematologic Malignancies.
@en
type
label
Single-Agent Post-Transplantat ...... with Hematologic Malignancies.
@ast
Single-Agent Post-Transplantat ...... with Hematologic Malignancies.
@en
prefLabel
Single-Agent Post-Transplantat ...... with Hematologic Malignancies.
@ast
Single-Agent Post-Transplantat ...... with Hematologic Malignancies.
@en
P2093
P2860
P1476
Single-Agent Post-Transplantat ...... with Hematologic Malignancies.
@en
P2093
Allen Chen
David M Loeb
Elad Jacoby
Elias Zambidis
Ephraim Fuchs
Heather J Symons
Kenneth R Cooke
Leo Luznik
Nicolas J Llosa
Rick Jones
P2860
P304
P356
10.1016/J.BBMT.2015.08.034
P577
2015-09-04T00:00:00Z